These findings suggest that PLX4032 induced autophagy through inhibition of MEK-Erk-p90RSK signaling pathways and phosphorylation of AMPK, and inhibition of autophagy by CQ can potently enhance the anti-tumor effect of PLX4032 in vivo. The gene discussed is RPS6KA1; the disease is neoplasm.